Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Clinical trial NCT01426802 · COMPLETED
Trial details
- NCT number
- NCT01426802
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-04-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.